VAP | Other infections | P | |
---|---|---|---|
Male/female | 23/13 | 14/18 | 0.099 |
Age (years) | 68.88 (15.57) | 64.41 (19.76) | 0.300 |
Sepsis/severe sepsis/septic shock | 7/22/7 | 15/7/10 | 0.411 |
APACHE II score | 18.25 (4.31) | 15.33 (5.03) | 0.200 |
WBCs (/μl) | 11530 (1179) | 14530 (1469) | 0.141 |
Monocytes | 234 (149) | 311 (49) | 0.422 |
Lymphocytes | 629 (896) | 685 (172) | 0.922 |
Neutrophils | 8299 (1342) | 9180 (1371) | 0.642 |
Use of steroids (n, %) | 12 (33.33) | 13 (28.12) | 0.501 |
Comorbidities (n, %) | |||
COPD | 9 (25.00) | 3 (9.38) | 0.083 |
DM | 9 (25.00) | 6 (18.75) | 0.439 |
CHF | 3 (8.33) | 7 (21.87) | 0.206 |
CRF | 4 (11.11) | 2 (6.25) | 0.414 |
Prior infections (n) | 2 | 1 | |
Number of failing organs (n) | |||
Two or more | 8 | 11 | |
Duration of hospitalization (days) | 18.93 (20.84) | 19.04 (27.90) | 0.151 |
Duration of mechanical ventilation (days) | 18.34 (21.11) | 26.76 (29.1) | 0.525 |
Bacterial causes (n, %) | |||
P. aeruginosa | 12 (33.33) | 4 (12.50) | |
A. baumannii | 7 (19.44) | 5 (15.62) | |
K. pneumoniae | 3 (8.33) | 5 (15.62) | |
E. coli | 1 (2.77) | 5 (15.62) | |
Ent. cloacae | 2 (5.55) | 2 (6.25) |